127 related articles for article (PubMed ID: 15200011)
1. Stability of liposomal formulations in physiological conditions for oral drug delivery.
Taira MC; Chiaramoni NS; Pecuch KM; Alonso-Romanowski S
Drug Deliv; 2004; 11(2):123-8. PubMed ID: 15200011
[TBL] [Abstract][Full Text] [Related]
2. Study of in vitro stability of liposomes and in vivo antibody response to antigen associated with liposomes containing GM1 after oral and subcutaneous immunization.
Fabani MM; Gargini R; Taira MC; Iacono R; Alonso-Romanowski S
J Liposome Res; 2002; 12(1-2):13-27. PubMed ID: 12604034
[TBL] [Abstract][Full Text] [Related]
3. Application of liposomes for development of oral vaccines: study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization.
Han M; Watarai S; Kobayashi K; Yasuda T
J Vet Med Sci; 1997 Dec; 59(12):1109-14. PubMed ID: 9450240
[TBL] [Abstract][Full Text] [Related]
4. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids.
Parmentier J; Becker MM; Heintz U; Fricker G
Int J Pharm; 2011 Feb; 405(1-2):210-7. PubMed ID: 21145956
[TBL] [Abstract][Full Text] [Related]
5. Combined strategies for liposome characterization during in vitro digestion.
Hermida LG; Sabés-Xamaní M; Barnadas-Rodríguez R
J Liposome Res; 2009; 19(3):207-19. PubMed ID: 19548842
[TBL] [Abstract][Full Text] [Related]
6. Liposomal formulation of mirfentanil hydrochloride.
Betageri GV; Segers J; Spaulding TC; Pejaver SK; Brittain HG
PDA J Pharm Sci Technol; 1996; 50(4):219-22. PubMed ID: 8810836
[TBL] [Abstract][Full Text] [Related]
7. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.
Hu S; Niu M; Hu F; Lu Y; Qi J; Yin Z; Wu W
Int J Pharm; 2013 Jan; 441(1-2):693-700. PubMed ID: 23089580
[TBL] [Abstract][Full Text] [Related]
8. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.
Justo OR; Moraes AM
J Pharm Pharmacol; 2005 Jan; 57(1):23-30. PubMed ID: 15638989
[TBL] [Abstract][Full Text] [Related]
9. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
10. Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract.
Ariën A; Goigoux C; Baquey C; Dupuy B
Life Sci; 1993; 53(16):1279-90. PubMed ID: 8412488
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.
Jin SE; Kim IS; Kim CK
Arch Pharm Res; 2015 Oct; 38(10):1822-9. PubMed ID: 25851624
[TBL] [Abstract][Full Text] [Related]
13. Liposomal diltiazem HCl as ocular drug delivery system for glaucoma.
Mokhtar Ibrahim M; Tawfique SA; Mahdy MM
Drug Dev Ind Pharm; 2014 Jun; 40(6):765-73. PubMed ID: 23570512
[TBL] [Abstract][Full Text] [Related]
14. Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
Carafa M; Marianecci C; Annibaldi V; Di Stefano A; Sozio P; Santucci E
Int J Pharm; 2006 Nov; 325(1-2):155-62. PubMed ID: 16884870
[TBL] [Abstract][Full Text] [Related]
15. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
[TBL] [Abstract][Full Text] [Related]
16. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
[TBL] [Abstract][Full Text] [Related]
17. Intradermal and follicular delivery of adapalene liposomes.
Kumar V; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
Alipour M; Halwani M; Omri A; Suntres ZE
Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
[TBL] [Abstract][Full Text] [Related]
19. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
Harasym TO; Cullis PR; Bally MB
Cancer Chemother Pharmacol; 1997; 40(4):309-17. PubMed ID: 9225948
[TBL] [Abstract][Full Text] [Related]
20. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
Mayer LD; Tai LC; Ko DS; Masin D; Ginsberg RS; Cullis PR; Bally MB
Cancer Res; 1989 Nov; 49(21):5922-30. PubMed ID: 2790807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
